The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Relationships between stable state inflammation and time to exacerbation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007
Some local markers indices of saliva inflammation in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004
Changes in urinary biomarkers between stable state and exacerbation of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013
Changes in EBC cytokine pattern during treatment of COPD exacerbation Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009
Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Inflammatory markers and HDAC activity in induced sputum of smokers and COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003